Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

US Patent 11744837 · Granted Sep 5, 2023

Estimated economic value: $34,277,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for shrinking pituitary tumors2025
Methods for imaging and treatment of somatostatin-receptor positive tumors2025
Methods of treating neuroepithelial tumors using selective glucocorticoid recept2025
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucoc2024
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort2024
Methods for shrinking pituitary tumors2024
Use of glucocorticoid receptor antagonists in combination with glucocorticoids t2024
Methods of treating neuroepithelial tumors using selective glucocorticoid recept2023
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort2023
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort2023
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucoc2022
Methods of treating cancer comprising administration of a glucocorticoid recepto2022